News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

A closeup shot of the Capitol dome with a flag flying in the center
Media Coverage

In the run-up to the 2026 midterm elections, the political parties in many states are working to redefine their congressional district maps to gain every possible edge. From California and Texas to Tennessee and Virginia, redistricting efforts have taken center stage. The Supreme Court has sanctioned partisan gerrymandering, and the system has evolved to one in which state legislature majorities get to determine who is most likely to fill those seats in Congress.

In short, gerrymandering has become a central feature of the system, not a bug. But what if we rethink the structure entirely?

Read More
On a sidewalk on a blanket sit a number of bags with designer logos. They are shades of red, black and cream. Behind the presentation, people stand around and sit by a body of water.
Media Coverage

Fake Hermès Birkin bags and other counterfeit luxury goods are popular not only with people on a budget, but also with those with deeper pockets, a new study suggests.

Researchers from the National University of Singapore analyzed millions of counterfeit purchases by American consumers from more than 24,000 U.S. zip codes on a major cross-border, e-commerce platform. They found that both lower- and higher-income individuals are “significantly more likely” to buy fake luxury items than middle-income consumers, according to a press release by INFORMS on Monday.

Read More
Three ants appear to push a small piece of something over a dip in a cement sidewalk
Media Coverage

A new study from INFORMS suggests warehouse robots perform better when they work together instead of operating independently.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Coronavirus Impacts Pharmaceutical Supply Chain

Coronavirus Impacts Pharmaceutical Supply Chain

Strategic Sourceror, May 15, 2020

It should come as little surprise that the novel coronavirus outbreak has led to the disruption - to one extent or another - of countless industries. However, some may be surprised to learn that one such sector is the pharmaceutical industry and, more specifically, the global supply chain it relies on to conduct business on an ongoing basis.

Q&A: What COVID-19 policies should governments impose? Comparing 10 interventions, weighing cost and quality-of-life trade-offs

Q&A: What COVID-19 policies should governments impose? Comparing 10 interventions, weighing cost and quality-of-life trade-offs

Harvard Kennedy School, May 13, 2020

Assistant Professor of Public Policy Soroush Saghafian, whose academic interests include applying operations research methods to health care management, has been working with the government of Bahrain to analyze the effectiveness of policies to address the coronavirus. Saghafian, who is a faculty affiliate of the Harvard PhD program in health policy and the Harvard Center for Health Decision Science, cautions that no one policy is best in all cases—and that governments must weigh cost and quality of life considerations. However, he says that closing businesses like cinemas and gyms for four months could be one of the most low-cost and effective measures. Saghafian shared analysis that he and his former PhD student (now an assistant professor of statistics and family medicine at Michigan State University) Alireza Boloori conducted in an HKS faculty working paper, “COVID-19: What Intervention Policies Are Most Effective? A Brief Report Using Data from Government of Bahrain.”

Dozens of coronavirus drugs are in development — what happens next?

Dozens of coronavirus drugs are in development — what happens next?

Nature, May 14, 2020

The world was waiting for any sign of hope in countering the COVID-19 pandemic when researchers released the first encouraging drips of data from a large clinical trial of the antiviral remdesivir last month. The drug, they said, reduced the time to recovery from COVID-19 by a few days — not enough to be branded a ‘cure’, but hopefully enough to relieve some pressure on overwhelmed health-care systems.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine